Cédric Blanpain, MD, PhD
Cedric Blanpain graduated as a Medical Doctor (1995), received his PhD in Medical Sciences (2001) and was board certified in internal medicine (2002) from the Université Libre de Bruxelles (ULB), Belgium. He performed a postdoctoral training in the laboratory of Elaine Fuchs, at the Rockefeller University from 2002 to 2006. Cédric Blanpain started his laboratory in October 2006 as “chercheur qualifié” of the Belgian Fonds National de la Recherche Scientifique (FNRS).
Cedric Blanpain received several prestigious and highly competitive awards including EMBO Young investigator award, ERC starting, consolidator and advanced grants, the outstanding young investigator award of the ISSCR 2012, the Liliane Bettencourt award for life sciences 2012, the Joseph Maisin Award for basic biomedical Science 2015, the Francqui prize 2020, the European Association for Cancer Research’s Mike Price Gold Medal Award 2022 and the momentum award of the ISSCR 2023. He has been elected member of the EMBO in 2012, the Belgian Royal Academy of Medicine, the Academia Europaea and the French Academy of Science - Institut de France (foreign member).
Alexandra Van Keymeulen, PhD
Alexandra Van Keymeulen received her PhD in Chemistry from Université Libre de Bruxelles (ULB) in 2000. Alexandra joined Henry Bourne Lab (University of California San Francisco, USA) as a postdoctoral fellow from 2002 to 2006.
Alexandra joined the laboratory in 2006 as a postdoctoral fellow and was appointed to a tenure position as “chercheur qualifié” (Assistant professor) in 2008 then Maître de recherché (Associate Professor) of the Belgian Fond National de la recherche Scientifique (FNRS) in 2015. She is leading projects on the mammary gland stem cells and on the cells of origin of breast cancers.
Marco Fioramonti, PhD
Marco Fioramonti obtained his PhD from Campus Bio-Medico University of Rome, Italy in 2016. Marco joined our laboratory as a postdoctoral fellow in November 2016. Marco is studying the cell of origin of breast cancer and the mechanisms regulating tumor heterogeneity.
Rahul Sarate, PhD
Rahul Sarate completed his PhD from ACTREC-Tata Memorial Centre, Mumbai in 2017 Rahul joined the lab as postdoctoral fellow in May 2017. He is studying the molecular and cellular mechanisms mediating tissue repair in the skin epidermis.
Kevin Bévant, PhD
Kevin Bévant obtained his PhD from the University of Rennes 1, France in 2021. Kevin joined the lab in June 2021 as a postdoctoral fellow. He is working on tumor heterogeneity and the identification of tumor states.
Chen Jiang, PhD
Chen Jiang received his M.S. from Nanjing University, China in 2015. He then obtained his Ph.D. from University of Marburg, Germany in 2021. In September 2021 he joined our lab as a postdoctoral fellow to study mechanisms regulating stem cell multipotency during tissue repair and tumor initiation.
Louciné Mitoyan, PhD
Louciné obtained her PhD from Aix-Marseille University (France) in 2021. She joined our laboratory as a postdoctoral fellow in April 2022. She aims to understand cell-cell communications and how tumor states identity is regulated.
Anqi Dong, PhD
Anqi Dong obtained her PhD from The Hong Kong University of Science and Technology in 2021. Anqi joined our lab as a postdoctoral fellow in August 2022. Anqi is interested in the mechanisms regulating tumor heterogeneity and tumor cell-stromal cell interactions.
Sebastiaan Vanuytven, PhD
Sebastiaan Vanuytven obtained his Master's degrees in Biomedical Sciences and Bioinformatics from the KU Leuven in 2015 and 2017, respectively. He then completed his graduate study in the groups of Prof. Thierry Voet (KU Leuven) and Prof. Peter Van Loo (Crick). Sebastiaan joined the lab in 2023, and his research will focus on untangling cellular heterogeneity in cancer through the use of single-cell (multi-)omics.
Yura Song, MS
Yura Song obtained her Master degree in Biochemistry from Ewha Womans University in 2018. She has worked in National Cancer Center in South Korea as bioinformatician from 2015 to 2018. Yura joined our laboratory in March 2018 and she is performing bioinformatic analysis of gene regulatory networks controlling development and cancers.
Lucile Crevet, MS
Lucile Crevet obtained her master’s degree from Université Lyon 1 in June 2019. Lucile joined the lab in October 2019 as a PhD student. Lucile is studying the oestrogen signalling in mammary gland and in breast cancer.
Andrea Pérez Gonzalez, MS
Andrea Pérez González obtained her BSc in Biotechnology in 2019 and she subsequently received her Degree in Pharmacy (BPharm/MPharm) in 2021, both from Universidad Francisco de Vitoria (Spain). She has conducted research internships in the University of Cambridge (Amgen European Scholar), Santiago de Compostela University and the New York Stem Cell Foundation. In August 2021, Andrea received a ITN Marie Sklodowska-Curie grant to join the laboratory as a PhD student. As part of the Evomet research project, she aims to characterize the tumor transition states involved in metastasis.
Mónica Jordán Pirla, MS
Mónica Jordán received her BSc in Biomedical Sciences in 2019 and she obtained her MSc in Biomedicine in Basic and Translational Research in Cancer in 2020, both awarded by the University of Barcelona. In August 2021, Mónica received a ITN Marie Sklodowska-Curie grant to join ChromaCure and the laboratory as a PhD student. She is studying the genes and signalling pathways involved in metastatic cancer dormancy.
Elodie Baudelet, MS
Elodie obtained her Master’s degree in Biomedical Sciences from the “Université Libre de Bruxelles” in 2021. She joined the lab to perform her master thesis in 2020 and is now performing a PhD since October 2021. Elodie is studying the gene regulatory network driving the specification of early cardiovascular progenitors and their differentiation into different cardiovascular cell lineages, using single cell approaches and an unbiased CRISPR-Cas9 screening.
Julie Sarrand, MD
Julie Sarrand obtained her medical degree (MD) at the Université libre de Bruxelles (ULB) in 2016. From 2016 to 2019, she has done internship in Internal general medicine and has since been a post-graduate in rheumatology. Julie joined our laboratory in October 2021. She's interested in tumor heterogeneity and more precisely in the characterization of gene regulatory networks controlling EMT.
Gabriel Windels, MS
Gabriel obtained his master at the Universite de Paris in 2021. He studied Biomedical Engineering and biotherapies with various extracurricular research activity. After that, worked on Bioinformatic profiling of tissue therapy donor at the French Bloodbank(EFS) for over one year before arriving at the Blanpain lab. Gabriel focuses on Bioinformatics in Clinical research and development and studies the profiling and description of cancer regulation and their heterogeneity at the single cell level in the context of regenerative cell therapies.
Brigida Novello, MS
Brigida Novello obtained her BSc in Biotechnology in 2019 and she completed her Master's Degree in Pharmaceutical Biotechnologies" in 2021, both at University of Padua (Italy). She aims to define the contribution of retrotranspons expression and viral mimicry during mammary gland development and breast tumorigenesis
Dan Engelman, MD
Dan Engelman obtained his medical degree (MD) at the Université libre de Bruxelles (ULB) in 2019. From 2019 to 2022, he has conducted an internship in internal medicine and since is in training in medical oncology. Dan joined our laboratory in October 2022. He is studying the effect of multiple oncogenic hits on skin stem cells and tumor initiation
Louise Anciaux (MS)
Louise Anciaux obtained her Master’s degree in Biomedical Sciences from the Université Catholique de Louvain (UCL) in 2022. She has joined our laboratory in October 2022. Louise is interested in tumor heterogeneity and is studying the gene regulatory network involved in chemotherapy and targeted therapy resistance, using single cell approaches and CRISPR-Cas9 loss of functions.
Anaïs Bauduin (MS)
Anaïs obtained her Master’s degree in Biomedical Sciences from the “Université Libre de Bruxelles” in 2023. She joined the lab to perform her master thesis in 2022 and after conducting a research internship at the University of Cambridge (Cambridge Stem Cell Institute) she is now performing a PhD in the lab since October 2023 . Anaïs is studying the cellular and molecular mechanisms of clonal competition upon oncogenic transformation during tissue regeneration.
Catherine Paulissen, BS
Catherine Paulissen received a BS in Medical Biology from la Haute Ecole André Vésale, Liège. Catherine has been working in the laboratory since December 2006.
Gaelle Bouvencourt, BS
Gaelle is studying a BS in Chemistry at Haute Ecole Provinciale de Hainaut (HEPH Condorcet). Gaelle Bouvencourt performed a rotation in our lab in 2009 and joined the group in February 2010.
Virginie Moers, PhD
Virginie Moers obtained her PhD in the Université Libre de Bruxelles in 2008 in the laboratory of Eric Belefroid. Virginie joined our laboratory in January 2011.
Christine Dubois, MS
Christine Dubois received a master degree in Biology from the Universite Libre de Bruxelles (ULB). Christine joined our lab in 2012 and is manager of the flow cytometry and cell sorting facility of the School of medicine.
Mélanie Liagre, BS
Mélanie Liagre received her BS in Biochemistry at Haute Ecole Provinciale de Hainaut (HEPH Condorcet) in 2012. She joined our lab in December 2012.
Sebastien Delcambre, MS
Sébastien Delcambre received his Master degree in medical biology from the University of Mons (June 2014). He joined the group in February 2015 and he is now working at the PDX facility.
Sophie Lemaire, BS
Sophie Lemaire received her BS in Medical Biology at Institut Paul Lambin in 2005. She worked at the CODA-CERVA during 9 years. She joined our lab in October 2015.
Samuel Scozzaro, MS
Samuel Scozzaro received a Master degree in Biomedical sciences from Université Libre de Bruxelles (ULB) in 2017. Samuel joined our laboratory in September 2017.
Anne-Lise Delaunois, MS
Anne-Lise Delaunois obtained her Master’s degree in Biomedical Sciences from the Université Catholique de Louvain in 2019. She joined our laboratory in February 2020.
Jérémy Blondeau, BS
Jérémy Blondeau received a BS in Medical Biology from la Haute École Louvain en Hainaut (HELHa), Montignies-sur-Sambre in 2019. Jérémy joined our laboratory in February 2020.
Zahra Zahedi, MS
Zahra Zahedi holds a MS in Animal Genetics and Breeding from TMU, Teheran, Iran and a MS in Molecular Biology from VUB, Bruxelles, Belgium. She started to work in the laboratory in March 2020.
Ena Shehu (Bs)
Ena Shehu obtained her Bachelor’s degree in Biomedical Sciences from the University of Liege in 2022. She joined our laboratory in August 2023.
Marylene Poelaert, MA
Marylène Poelaert holds a Master in history and a Master in information science. She has been chief of staff for the President (Rector) of the Université Libre de Bruxelles for more than seven years. Marylène is now Prof. Cedric Blanpain’s personal assistant and responsible for the administrative management of the laboratory of stem cells and cancer.
Previous lab members
Former PhD students
Postdoctoral scholar in the Morsut lab at the University of Southern California
Postdoctoral researcher at IRB Barcelona, Spain
Data Protection Manager & personnel development lead at Mydata-TRUST, Belgium
Biomarker Lead at iTeos Therapeutics, Belgium
Dermatologist at Erasme hospital, Belgium
Jean Christophe Larsimont
Chief Technical Officer at Belgian Process Solutions, Dion-Valmont, Belgium
Senior scientist at Iteos Therapeutics, Belgium
Lead Biologist-Project Manager, CISTIM, Leuven, Belgium
Solftware developer at Labsoft, France
Senior Scientific Writer at GSK, Belgium
Personal Development Lead and DPO at MyData-Trust, Belgium
Khalil Kass Youssef
Postdoc in Nieto lab, EMBO fellow, Alicante, Spain
Head of the department of cardiology, Erasme hospital, ULB, Belgium
Former postdoctoral researchers
Postdoctoral researcher at The Cancer Research Center of Marseille, France
Plasmid engineering team leader at Polyplus, France
Principal Scientist in Cancer Research at Boehringer Ingelheim in Vienna
Director of the Laboratory of Histology at the Université libre de Bruxelles
Group Leader at the Novo Nordisk Foundation Center for Stem Cell Biology, DanStem, University of Copenhagen, Denmark
Head of the animal facility of the Université libre de Bruxelles, Belgium
Principal Investigator at Champalimaud Foundation, Lisbon, Portugal
QA assurance stérilité at GSK, Belgium
Associate Director, Clinical Science Lead at GSK, Belgium
CSO at T-knife Therapeutics, San Francisco, USA and Berlin, Germany
Group leader at BioMedX Institute, Heidelberg, Germany
Senior Director, Project Head at iTeos Therapeutics SA, Belgium
WELBIO/FNRS principal investigator, ULB, Belgium
Ana Sofia Rocha
Researcher at the Bellvitge Biomedical Research Institute - IDIBELL, Spain
Principal Scientist at Seagen, Seattle, Washington, USA
Clinical Research Director at Sanofi, France
Head of Experimental Pharmacology at Biophytis, Paris, France
Postdoctoral Fellow at the Université de Reims, France
CNRS researcher at RESTORE, Université Toulouse III - Paul Sabatier, France
Group leader ATIP-Avenir at INSERM-Université de Marseille, France